Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa

Factors driving the increase in drug-resistant tuberculosis (TB) in the Eastern Cape Province, South Africa, are not understood. A convenience sample of 309 drug-susceptible and 342 multidrug-resistant (MDR) TB isolates, collected July 2008-July 2009, were characterized by spoligotyping, DNA fingerprinting, insertion site mapping, and targeted DNA sequencing. Analysis of molecular-based data showed diverse genetic backgrounds among drug-sensitive and MDR TB sensu stricto isolates in contrast to restricted genetic backgrounds among pre-extensively drug-resistant (pre-XDR) TB and XDR TB isolates. Second-line drug resistance was significantly associated with the atypical Beijing genotype. DNA fingerprinting and sequencing demonstrated that the pre-XDR and XDR atypical Beijing isolates evolved from a common progenitor; 85% and 92%, respectively, were clustered, indicating transmission. Ninety-three percent of atypical XDR Beijing isolates had mutations that confer resistance to 10 anti-TB drugs, and some isolates also were resistant to para-aminosalicylic acid. These findings suggest the emergence of totally drug-resistant TB.

[1]  P. V. van Helden,et al.  Spread of a Low-Fitness Drug-Resistant Mycobacterium tuberculosis Strain in a Setting of High Human Immunodeficiency Virus Prevalence , 2008, Journal of Clinical Microbiology.

[2]  T. Holtz,et al.  Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[3]  P. V. van Helden,et al.  Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[4]  Neel R Gandhi,et al.  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa , 2006, The Lancet.

[5]  Nalin Rastogi,et al.  Spoligotype Signatures in the Mycobacterium tuberculosis Complex , 2006, Journal of Clinical Microbiology.

[6]  D van Soolingen,et al.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology , 1997, Journal of clinical microbiology.

[7]  P. V. van Helden,et al.  inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa? , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  C. D. Long,et al.  The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis , 2006, Science.

[9]  C. Kvasnovsky,et al.  Extensively Drug-Resistant TB in Eastern Cape, South Africa: High Mortality in HIV-Negative and HIV-Positive Patients , 2011, Journal of acquired immune deficiency syndromes.

[10]  S. Rüsch-Gerdes,et al.  Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens , 2009, Journal of Clinical Microbiology.

[11]  C. G. Bayliss.  TREATMENT OF PULMONARY TUBERCULOSIS , 1967, The Medical journal of Australia.

[12]  J. T. Crawford,et al.  Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis , 1994, Journal of clinical microbiology.

[13]  P. V. van Helden,et al.  An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  P. V. van Helden,et al.  Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa , 2010, Emerging infectious diseases.

[15]  George M Church,et al.  Tuberculosis Drug Resistance Mutation Database , 2009, PLoS medicine.

[16]  R. Gie,et al.  Classification of drug-resistant tuberculosis in an epidemic area , 2000, The Lancet.

[17]  Thomas C Victor,et al.  Patients with active tuberculosis often have different strains in the same sputum specimen. , 2004, American journal of respiratory and critical care medicine.

[18]  D. Enarson,et al.  XDR tuberculosis: an indicator of public-health negligence , 2006, The Lancet.

[19]  D. Coetzee,et al.  Epidemic Levels of Drug Resistant Tuberculosis (MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa , 2010, PloS one.

[20]  C. Kvasnovsky,et al.  Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study , 2010, The Lancet.

[21]  Thomas R. Ioerger,et al.  Genome Analysis of Multi- and Extensively-Drug-Resistant Tuberculosis from KwaZulu-Natal, South Africa , 2009, PloS one.

[22]  I. Mokrousov,et al.  Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia. , 2002, Research in microbiology.

[23]  G. Tyrrell,et al.  Canadian Multicenter Laboratory Study for Standardized Second-Line Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis , 2011, Journal of Clinical Microbiology.

[24]  A. W. Sturm,et al.  Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. , 2007, Clinical Infectious Diseases.

[25]  Parissa Farnia,et al.  Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. , 2009, Chest.

[26]  T. Victor,et al.  Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[27]  P. V. van Helden,et al.  Safe Mycobacterium tuberculosis DNA Extraction Method That Does Not Compromise Integrity , 2006, Journal of Clinical Microbiology.

[28]  R. O'brien,et al.  Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. , 2008, American journal of respiratory and critical care medicine.

[29]  C. Dye,et al.  Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229) , 1998 .

[30]  P. V. van Helden,et al.  Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[31]  P. V. van Helden,et al.  Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis. , 2012, Microbial drug resistance.